Physician profile
Kersthine Andre
NPI 1710326293
$3,418.73
in general payments reported to CMS, 2019-2025
18 companies · $321 in 2025
The $321 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $312 · 2021: $116 · 2022: $424 · 2023: $820 · 2024: $296 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,436.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $994.59 | 2019-2024 | Evenity |
| Abbott Laboratories | $490.82 | 2019-2024 | Proclaim |
| Cequr Corporation | $476.38 | 2023-2025 | Cequr Simplicity |
| Sanofi-Aventis U.S. LLC | $441.13 | 2019-2025 | |
| Novo Nordisk INC | $426.98 | 2019-2023 | |
| Dexcom, INC. | $160.52 | 2019-2025 | Dexcom G6 Transmitter |
| Tandem Diabetes Care, INC. | $86.84 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Valeritas, INC. | $86.44 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $61.50 | 2023 | Lifevest |
| Axsome Therapeutics, INC. | $35.00 | 2025 | Auvelity |
| Lilly USA, LLC | $34.97 | 2019 | |
| Pfizer INC. | $29.08 | 2025 | |
| Corcept Therapeutics | $28.69 | 2019 | |
| Medtronic, INC. | $16.21 | 2023 | Inpen Smart Insulin Delivery System |
| Lifescan, INC. | $13.31 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $12.42 | 2019 | |
| Xeris Pharmaceuticals, INC. | $12.33 | 2022 | |
| Medtronic Minimed, INC. | $11.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kersthine Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.